MedTrace Logo

Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS

NCT05058742 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-10-25

No results posted yet for this study

Summary

Critical ill COVID-19 patients often develop respiratory, hemodynamic and neuropsychiatric complications. An imbalance of sympatho-parasympathetic nervous system is discussed as one of the reasons. The nervus vagus is essential for controlling the sympatho-parasympathetic nervous system and the inflammatory processes.

Aim of this study is to evaluate whether Nervus vagus stimulation decreases the rate of complications (e.g. need of mechanical ventilation, hospital stay, mortality) in critical ill patients.

Conditions

Interventions

DEVICE

AuriStim

Auricular vagal nerve Stimulator, which Targets the auricular branches of the vagal nerve

Sponsors & Collaborators

  • Vienna Hospital Association

    lead OTHER_GOV

Principal Investigators

  • Alexander Zoufaly, MD · Klinik Favoriten

  • Eugenijus Kaniusas, Prof. Dr. · Vienna University of Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05058742 on ClinicalTrials.gov